Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Calgary

$60,000.00

Organic synthesis of biologically active compounds and organosulfur/ selenium chemistry

EF 2011-12

Résumé
Our work is in the area of synthetic organic chemistry, generally directed toward the synthesis of biologically interesting molecules, and frequently based on novel aspects of organosulfur and selenium chemistry. Our program includes: 1) New cyclization protocols based on unsaturated sulfones are being developed that provide efficient new routes to a variety of alkaloids and related heterocycles, including several dendrobatid alkaloids that have cardiotonic and neurochemical activities, the anticancer agents motuporamine A and B, and others that are in progress. 2) We are investigating a new variation of the Morita-Baylis-Hillman reaction, which is a valuable method for constructing strategic carbon-carbon bonds. We have coupled this process with other reactions that provide convenient access to substituted piperidines and pyridines, common structures among medicinal compounds. 3) Glutathione peroxidase is a selenoenzyme that protects higher organisms from oxidative stress by catalytically destroying harmful peroxides that cause inflammation, cardiovascular damage and other deleterious effects. We are developing novel small-molecule selenium compounds with unusual structural motifs that mimic the activity of the enzyme, and we are investigating the mechanisms by which they function. Several compounds that we have discovered are more effective catalysts than ebselen, a compound being tested in Phase III clinical trials for treating cardiovascular disease by the Daiichi Pharmaceutical Co. in Japan. 4) We recently completed the enantioselective synthesis of virantmycin, a rare natural product with powerful antiviral activity. Methodology that was developed for this purpose is being investigated for new applications, mainly as an approach to novel unnatural amino acids that are potentially useful in peptidomimetic drugs and as building blocks for the synthesis of other types of alkaloids.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
924-2009
Name nom
Back, Thomas
Department département
Chemistry
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2009
Award amount
60000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
24
Committee name en
Inorganic & Organic Chemistry
Committee name fr
Chimie inorg. et org.
Area of application code
1202
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Physical sciences
Area of application fr
Sciences physiques
Research subject code
3700
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic chemistry
Research subject fr
Chimie organique
Partie
3
Nb partie
5
Application title
Organic synthesis of biologically active compounds and organosulfur/ selenium chemistry
Keyword
NSERC
Application summary
Our work is in the area of synthetic organic chemistry, generally directed toward the synthesis of biologically interesting molecules, and frequently based on novel aspects of organosulfur and selenium chemistry. Our program includes: 1) New cyclization protocols based on unsaturated sulfones are being developed that provide efficient new routes to a variety of alkaloids and related heterocycles, including several dendrobatid alkaloids that have cardiotonic and neurochemical activities, the anticancer agents motuporamine A and B, and others that are in progress. 2) We are investigating a new variation of the Morita-Baylis-Hillman reaction, which is a valuable method for constructing strategic carbon-carbon bonds. We have coupled this process with other reactions that provide convenient access to substituted piperidines and pyridines, common structures among medicinal compounds. 3) Glutathione peroxidase is a selenoenzyme that protects higher organisms from oxidative stress by catalytically destroying harmful peroxides that cause inflammation, cardiovascular damage and other deleterious effects. We are developing novel small-molecule selenium compounds with unusual structural motifs that mimic the activity of the enzyme, and we are investigating the mechanisms by which they function. Several compounds that we have discovered are more effective catalysts than ebselen, a compound being tested in Phase III clinical trials for treating cardiovascular disease by the Daiichi Pharmaceutical Co. in Japan. 4) We recently completed the enantioselective synthesis of virantmycin, a rare natural product with powerful antiviral activity. Methodology that was developed for this purpose is being investigated for new applications, mainly as an approach to novel unnatural amino acids that are potentially useful in peptidomimetic drugs and as building blocks for the synthesis of other types of alkaloids.